US FDA greenlights nivolumab for use before surgery for NSCLC

Low-Dose CT, ctDNA May Partner for Lung Cancer Detection

Award Lecture Highlights Tumor Evolution Through Liquid Biopsy

In Brief for May 11, 2022

US FDA’s Review of Single-Country ‘Me Too’ Drugs: A Clinical Trialist Perspective

Panel Explores Emerging Treatments and Sequencing Strategies for Patients with Advanced NSCLCs Driven by Rare Oncogenes

Evidence Supports Adding Biological, Pathological, and Molecular Assessments to the TNM Lung Cancer Staging System

Renowned Researcher Fred Hirsch Delivers 2022 Heine H. Hansen Award Lecture

In Brief for May 25, 2022

Real-World Data from Taiwan Shows Stage Shift Has Improved Lung Cancer Survival Rates

In Brief for June 8, 2022

In Brief for June 22, 2022